Amylyx Pharmaceuticals, Inc.
AMLXDrug Manufacturers - Specialty & Generic
$28.68+2.17%As of Oct 29vs prior close
- Market cap
- $3.6B
- P/E (TTM)
- –
- From 52W high
- −27.69%
- EPS (YE25)
- -$1.53
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
35
Crowded AscentBottom 21% of the scored universe
Growth44
Quality24
Value26
Momentum85
Resilience30
Growth
$0revenue, YE25
YE21 $285KYE25 $0
Connections
Revenue to profitQ3 YE24
The operating loss was 18188% of revenue, wider by 18206 pts on a year.
Who owns it
2funds